These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Comparison between growth characteristics of an Epstein--Barr virus (EBV)-genome-negative lymphoma line and its EBV-converted subline in vitro. Steinitz M; Klein G Proc Natl Acad Sci U S A; 1975 Sep; 72(9):3518-20. PubMed ID: 171663 [TBL] [Abstract][Full Text] [Related]
23. Specific sites for EBV association in the Namalwa Burkitt lymphoma cell line and in a lymphoblastoid line transformed in vitro with EBV. Caporossi D; Vernole P; Porfirio B; Tedeschi B; Frezza D; Nicoletti B; Calef E Cytogenet Cell Genet; 1988; 48(4):220-3. PubMed ID: 2854770 [TBL] [Abstract][Full Text] [Related]
24. High susceptibility of an Epstein-Barr virus-converted Burkitt's lymphoma cell line to cytotoxic drugs. Okano M Leuk Res; 1997 May; 21(5):469-71. PubMed ID: 9225077 [TBL] [Abstract][Full Text] [Related]
25. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells. Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014 [TBL] [Abstract][Full Text] [Related]
26. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression. Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641 [TBL] [Abstract][Full Text] [Related]
27. Examination of Epstein-Barr virus and C-type proviral sequences in American and African lymphomas and derivative cell lines. Pizzo PA; Chattopadhyay SK; Magrath IT; Del Giacco E; Sherrick D; Gray T Cancer Res; 1981 Aug; 41(8):3165-71. PubMed ID: 6265077 [TBL] [Abstract][Full Text] [Related]
28. Integration of a short Epstein-Barr virus DNA fragment in a B95-8 virus converted Burkitt lymphoma line expressing Epstein-Barr nuclear antigens EBNA2 and EBNA5. Trivedi P; Cuomo L; de Campos-Lima PO; Imreh MP; Kvarnung K; Klein G; Masucci MG J Gen Virol; 1993 Jul; 74 ( Pt 7)():1393-8. PubMed ID: 8393080 [TBL] [Abstract][Full Text] [Related]
29. Cell-surface immunoglobulin and insulin receptor expression in an EBV-negative lymphoma cell line and its EBV-converted sublines. Spira G; Aman P; Koide N; Lundin G; Klein G; Hall K J Immunol; 1981 Jan; 126(1):122-6. PubMed ID: 6256436 [TBL] [Abstract][Full Text] [Related]
30. Surface glycoprotein patterns of normal and malignant human lymphoid cells. II. B cells, B blasts and Epstein-Barr virus (EBV)-positive and -negative B lymphoid cell lines. Nilsson K; Andersson LC; Gahmberg CG; Wigzell H Int J Cancer; 1977 Nov; 20(5):708-16. PubMed ID: 200571 [No Abstract] [Full Text] [Related]
31. Antigen-inducing ability of herpesvirus papio in human and baboon lymphoma lines, compared to Epstein-Barr virus. Klein G; Falk L; Falk K Intervirology; 1978; 10(3):153-64. PubMed ID: 210135 [TBL] [Abstract][Full Text] [Related]
32. Differential expression of nucleoskeleton- and cytoskeleton-associated proteins in Burkitt lymphoma-derived and Epstein-Barr virus-immortalized lymphoblastoid cell lines. Szekely L; Pokrovskaja K; Klein G Cell Growth Differ; 1997 May; 8(5):599-609. PubMed ID: 9149911 [TBL] [Abstract][Full Text] [Related]
33. Shedding of anti-IgM from antibody-coated human lymphoma lines: differences between Epstein-Barr virus-negative lines and their virus-converted sublines. Yefenof E; Lundin L; Klein G Eur J Immunol; 1978 Mar; 8(3):190-3. PubMed ID: 207534 [TBL] [Abstract][Full Text] [Related]
34. Heterogeneity of Epstein-Barr virus derived from P3HR-1 cells. zur Hausen H; Fresen KO IARC Sci Publ (1971); 1978; (20):391-6. PubMed ID: 215522 [TBL] [Abstract][Full Text] [Related]
35. Correlated expression of a B-lymphocyte-specific glycoprotein (gp27/35) and the EBV receptor/C3 receptor complex in sublines from the same Burkitt lymphoma. Klein G; Hyman R; Trowbridge I Int J Cancer; 1979 Jan; 23(1):37-41. PubMed ID: 215562 [TBL] [Abstract][Full Text] [Related]
36. SH2D1A expression in Burkitt lymphoma cells is restricted to EBV positive group I lines and is downregulated in parallel with immunoblastic transformation. Nagy N; Maeda A; Bandobashi K; Kis LL; Nishikawa J; Trivedi P; Faggioni A; Klein G; Klein E Int J Cancer; 2002 Aug; 100(4):433-40. PubMed ID: 12115526 [TBL] [Abstract][Full Text] [Related]
38. Differences in EBV receptor concentration between in vitro EBV-converted lymphoma sublines reflect biological differences between the converting viral substrains. Klein G; Manneborg A; Steinitz M Int J Cancer; 1979 Feb; 23(2):197-200. PubMed ID: 216641 [TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus-induced proteins. IV. Characterization of an EBV-associated phosphopolypeptide. Mueller-Lantzsch N; Yamamoto N J Gen Virol; 1981 Aug; 55(Pt 2):333-41. PubMed ID: 6270267 [TBL] [Abstract][Full Text] [Related]
40. Modulation of expression of insulin and IGF-I receptor by Epstein-Barr virus and its gene products LMP and EBNA-2 in lymphocyte cell lines. Kriauciunas KM; Goldstein BJ; Lipes MA; Kahn CR J Cell Physiol; 1993 Mar; 154(3):486-95. PubMed ID: 8382208 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]